Ventyx Biosciences to Participate in Two Upcoming Investor Conferences
06 Marzo 2024 - 2:00PM
Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a
clinical-stage biopharmaceutical company focused on advancing novel
oral therapies that address a broad range of inflammatory diseases
with significant unmet medical need, today announced that Company
executives will participate in the following upcoming investor
conferences:
- Event: Jefferies Biotech on the Bay
SummitLocation: Miami, FL Date: Wednesday, March 13,
2024
- Event: Barclays 26th Annual Global Healthcare
ConferenceLocation: Miami, FL Date: Thursday, March 14,
2024 Time: 10:45-11:10 AM ET
A webcast of the Barclays presentation will be
available in the Investors and News section of the Ventyx website
at www.ventyxbio.com. A webcast replay will also be available on
this website shortly after conclusion of the event for thirty
days.
About Ventyx Biosciences
Ventyx is a clinical-stage biopharmaceutical
company focused on developing innovative oral medicines for
patients living with autoimmune and inflammatory disorders. We
believe our ability to efficiently discover and develop
differentiated drug candidates will allow us to address important
unmet medical need with novel oral therapies that can shift
immunology markets from injectable to oral drugs. Our current
pipeline includes internally discovered clinical programs targeting
TYK2, S1P1R and NLRP3, positioning us to become a leader in the
development of oral immunology therapies. Ventyx is headquartered
in San Diego, California. For more information about Ventyx, please
visit www.ventyxbio.com.
Investor Relations ContactPatti BankManaging
DirectorICR Westwicke(415) 513-1284IR@ventyxbio.com
Grafico Azioni Ventyx Biosciences (NASDAQ:VTYX)
Storico
Da Ago 2024 a Set 2024
Grafico Azioni Ventyx Biosciences (NASDAQ:VTYX)
Storico
Da Set 2023 a Set 2024